Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study

Table 1 Subject characteristics and mental health service utilization by treatment group

	NLAI (N = 289)		p^a	LAI (N = 178)		p^b	p^c
	Before	After	p^a	Before	After	p^b	p^c
Age, mean year (SD)	45.6 (16.2)			40.4 (11.9)			0.0001
Men, n (%)	156 (54)			100 (56)			0.702
Hospitalization, n (%)	14 (4.8)	18 (6.2)	0.586	54 (30.3)	21 (11.8)	< 0.0001
Length of stay, mean days (SD)	35 (10.5)	37 (12.2)	0.069	33 (28.8)	35 (19.8)	0.890
Emergency room visit, n (%)	21 (7.3)	30 (10.4)	0.241	64 (36.0)	14 (7.9)	< 0.0001

Fisher exact test was used to compare differences for categorical variables; t-test was used to compare differences for continuous variables. LAI, patients receiving a long-acting injection of paliperidone; NLAI, patients receiving only oral antipsychotic
^adifferences before and after treatment in the NLAI group
^bdifferences before and after treatment in the LAI group
^cdifferences between the NLAI and LAI groups

ISSN: 1471-244X